HomeHALO • NASDAQ
add
Halozyme Therapeutics, Inc.
$62.21
Makalipas ang Oras ng Trabaho:(0.31%)+0.19
$62.40
Sarado: Dis 12, 4:03:49 PM GMT-5 · USD · NASDAQ · Disclaimer
Nakaraang pagsara
$61.90
Sakop ng araw
$61.28 - $62.64
Sakop ng taon
$46.39 - $79.50
Market cap
7.32B USD
Average na Volume
2.60M
P/E ratio
13.08
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 354.26M | 22.12% |
Gastos sa pagpapatakbo | 63.85M | 8.21% |
Net na kita | 175.22M | 27.89% |
Net profit margin | 49.46 | 4.72% |
Kita sa bawat share | 1.72 | 35.43% |
EBITDA | 236.84M | 30.02% |
Aktuwal na % ng binabayarang buwis | 19.97% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 701.96M | 5.35% |
Kabuuang asset | 2.22B | 4.87% |
Kabuuang sagutin | 1.72B | 3.12% |
Kabuuang equity | 503.92M | — |
Natitirang share | 117.60M | — |
Presyo para makapag-book | 14.43 | — |
Return on assets | 25.49% | — |
Return on capital | 27.84% | — |
Cash Flow
Net change in cash
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 175.22M | 27.89% |
Cash mula sa mga operasyon | 178.60M | 54.80% |
Cash mula sa pag-invest | 201.61M | 220.38% |
Cash mula sa financing | -22.40M | -220.69% |
Net change in cash | 357.80M | 1,166.61% |
Malayang cash flow | 104.89M | -1.17% |
Tungkol
Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment.
The company was founded in 1998 and went public in 2004. Halozyme is headquartered in San Diego, California. Wikipedia
Itinatag
1998
Headquarters
Website
Mga Empleyado
350
